CMH Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

CMH Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$388K	Buy	773 +6	+0.8%	+$2.88K	0.06%	101
2026 Q1	$377K	Buy	+767	New	+$416K	0.06%	100
2020 Q1	–	Sell	-379	Closed	-$123K	–	58
2019 Q4	$123K	Sell	379 -300	-44%	-$91K	0.06%	52
2019 Q3	$198K	Hold	679	–	–	0.11%	51
2019 Q2	$199K	Sell	679 -200	-23%	-$55.1K	0.12%	49
2019 Q1	$241K	Buy	+879	New	+$219K	0.15%	52

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CMH Wealth Management's TMO Position: Q2 2026 in Review

CMH Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.78% in Q2 2026, buying an estimated $2.88K and bringing the position to 773 shares worth $388K. The position accounts for 0.06% of the portfolio, ranked #101.

CMH Wealth Management first reported a position in TMO in Q1 2019 and has held it in 6 quarters since. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

CMH Wealth Management held 773 shares of Thermo Fisher Scientific worth $388K as of Q2 2026.
CMH Wealth Management bought 6 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.88K.
Thermo Fisher Scientific made up 0.06% of CMH Wealth Management's portfolio in Q2 2026, its #101 holding.
CMH Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 6 quarters since.
429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CMH Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.